ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent.

Annalisa Nobili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.